Information, not a decision

Cervical cancer: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 12 Nov 2026

Open trials (619)

NCT07240220	No phase	The Mother-Daughter Project: Merck-4	Recruiting
NCT06319963	Phase 1/2	A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer	Recruiting
NCT06079671	Phase 3	Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)	Recruiting
NCT07928466	Phase 3	Study to Test Shorter Duration Chemoradiation Therapy Versus Standard Duration Chemoradiation Therapy for Cervical Cancer	Not yet recruiting
NCT07061977	Phase 3	Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer	Recruiting
NCT06241781	Phase 2	Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer	Recruiting
NCT07216703	Phase 3	A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)	Recruiting
NCT06669533	No phase	Use Misoprostol to Optimize Prevention of Cervical Cancer	Recruiting
NCT06952660	Phase 4	Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer	Recruiting
NCT06760819	Phase 2	A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)	Recruiting
NCT06465069	Phase 1	A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors	Recruiting
NCT06400472	Phase 1	A Study of Sofe-M in Participants With Selected Advanced Solid Tumors	Recruiting

607 more in the doctor's list on the site.

Phase 3 trials that ended in the last 90 days

No phase 3 trial in this list ended in the last 90 days.

Guidelines

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 12 Nov 2026

https://frontlightresearch.com/en/doctor/cervical-cancer/tumor-board